| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.00B | +19.8% |
| Cost of Revenue | $1.29B | +13.4% |
| Gross Profit | $707.3M | +33.4% |
| R&D Expense | $14.3M | +19.2% |
| SG&A Expense | $284.6M | +31.6% |
| Operating Income | $387.7M | +34.9% |
| Interest Expense | $58.3M | -12.9% |
| Pre-tax Income | $329.4M | +49.5% |
| Income Tax | $82.9M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.1M | +46.9% |
| Accounts Receivable | $220.4M | +31.0% |
| Inventory | $286.1M | +47.2% |
| Current Assets | $592.7M | +39.7% |
| Total Assets | $837.0M | +21.0% |
| Current Liabilities | $203.7M | +35.6% |
| Long-term Debt | $833.1M | -2.8% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $199.6M | -7.4% |
| Investing Cash Flow | -$1.8M | +0.0% |
| Financing Cash Flow | -$175.1M | +13.2% |
| +51.0% |
| Net Income | $246.5M | +48.9% |
| EPS (Basic) | $1.89 | +52.4% |
| EPS (Diluted) | $1.86 | +51.2% |
| Total Liabilities |
| $1.04B |
| +2.7% |
| Stockholders' Equity | -$205.9M | +36.4% |